Compounds > pentalenene
Page last updated: 2024-09-26

pentalenene

Description

pentalenene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11009055
CHEBI ID17251
MeSH IDM0083088

Synonyms (11)

Synonym
(1r,3as,5as,8ar)-1,2,3,3a,5a,6,7,8-octahydro-1,4,7,7-tetramethylcyclopenta[c]pentalene
(1alpha,3a alpha,5a beta,8ar*)-1,2,3,3a,5a,6,7,8-octahydro-1,4,7,7-tetramethylcyclopenta(c)pentalene
(1r,3as,5as,8ar)-1,4,7,7-tetramethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene
CHEBI:17251
(+)-pentalenene
73306-73-7
pentalenene
cyclopenta[c]pentalene
(1r,2r,5s,8s)-2,6,10,10-tetramethyltricyclo[6.3.0.01,5]undec-6-ene
Q27102286
DTXSID101126804

Drug Classes (2)

ClassDescription
sesquiterpeneA C15 terpene.
ortho-fused tricyclic hydrocarbon
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.53)18.7374
1990's1 (5.26)18.2507
2000's6 (31.58)29.6817
2010's7 (36.84)24.3611
2020's3 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
sesquiterpenes[no description available]medium80
cyclopentane[no description available]medium190cycloalkane;
cyclopentanes;
volatile organic compound		non-polar solvent
epi-isozizaene[no description available]medium10sesquiterpene
psilocybin[no description available]medium10organic phosphate;
tertiary amino compound;
tryptamine alkaloid		fungal metabolite;
hallucinogen;
prodrug;
serotonergic agonist
rhodium[no description available]medium10cobalt group element atom
hippolachnin a[no description available]medium10
osmium[no description available]medium10iron group element atom;
platinum group metal atom
fulvene[no description available]medium10fulvenes
pyrrolidine[no description available]medium10azacycloalkane;
pyrrolidines;
saturated organic heteromonocyclic parent
farnesyl pyrophosphate[no description available]medium40farnesyl diphosphateEscherichia coli metabolite;
mouse metabolite
ketene[no description available]medium10ketene
arenaemycin e[no description available]medium10alpha,beta-unsaturated monocarboxylic acid;
organic heterotricyclic compound;
sesquiterpene lactone;
spiro-epoxide		antimicrobial agent;
bacterial metabolite;
EC 1.2.1.12 [glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)] inhibitor
carbene[no description available]medium10carbene;
methanediyl
methane[no description available]medium10alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
manganese[no description available]medium10elemental manganese;
manganese group element atom		Escherichia coli metabolite;
micronutrient
guaiazulene[no description available]low00sesquiterpene
guaiene[no description available]low00sesquiterpene
alpha-bergamotene[no description available]low00bridged compound;
polycyclic olefin;
sesquiterpene		plant metabolite;
volatile oil component
alpha-curcumene[no description available]low00sesquiterpene
zingiberene[no description available]low00cyclohexadiene;
sesquiterpene
trichodiene[no description available]low00sesquiterpene
eudesmane[no description available]low00sesquiterpene;
terpenoid fundamental parent
germacrene a[no description available]low00germacrene;
sesquiterpene
cedrene[no description available]low00bridged compound;
carbotricyclic compound;
polycyclic olefin;
sesquiterpene		human urinary metabolite;
volatile oil component
guaiane[no description available]low00sesquiterpene;
terpenoid fundamental parent
cadinane[no description available]low00sesquiterpene;
terpenoid fundamental parent
drimane[no description available]low00sesquiterpene;
terpenoid fundamental parent
valencene[no description available]low00carbobicyclic compound;
polycyclic olefin;
sesquiterpene
amorpha-4,11-diene[no description available]low00octahydronaphthalenes;
sesquiterpene
sativene[no description available]low00bridged compound;
sesquiterpene
phenanthrene[no description available]low00ortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes		environmental contaminant;
mouse metabolite
fluorene[no description available]low00ortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon
anthracene[no description available]low00acene;
anthracenes;
ortho-fused tricyclic hydrocarbon
ConditionIndicatedRelationship StrengthStudiesTrials
Disease Models, Animal0low10
Inflammation0low10
Innate Inflammatory Response0low10

Research Highlights

Dosage (1)

ArticleYear
Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists.
Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue: 1		2013
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]